Generic Sweden Management

How has Jonas Jegerborn's remuneration changed compared to Generic Sweden's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	kr23m
Dec 31 2023	n/a	n/a	kr23m
Sep 30 2023	n/a	n/a	kr24m
Jun 30 2023	n/a	n/a	kr23m
Mar 31 2023	n/a	n/a	kr21m
Dec 31 2022	kr3m	n/a	kr20m
Sep 30 2022	n/a	n/a	kr19m
Jun 30 2022	n/a	n/a	kr18m
Mar 31 2022	n/a	n/a	kr19m
Dec 31 2021	kr3m	n/a	kr18m
Sep 30 2021	n/a	n/a	kr17m
Jun 30 2021	n/a	n/a	kr15m
Mar 31 2021	n/a	n/a	kr13m
Dec 31 2020	kr3m	n/a	kr11m
Sep 30 2020	n/a	n/a	kr10m
Jun 30 2020	n/a	n/a	kr10m
Mar 31 2020	n/a	n/a	kr9m
Dec 31 2019	kr2m	kr1m	kr9m

Compensation vs Market: Jonas's total compensation ($USD262.85K) is about average for companies of similar size in the Swedish market ($USD255.46K).

Compensation vs Earnings: Jonas's compensation has been consistent with company performance over the past year.

CEO

Jonas Jegerborn (51 yo)

no data

Tenure

kr2,769,000

Compensation

Mr. Jonas Jegerborn serves as the Chief Executive Officer and President at Generic Sweden AB.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jonas Jegerborn	President & CEO	no data	kr2.77m	1.47% SEK 8.6m
Susanne Lundin	Chief Financial Officer	3.3yrs	no data	no data
Magnus Rasmusson	Chief Technology Officer	4.4yrs	no data	no data
Gustav Molander	Sales Director	5.4yrs	no data	no data
Madelene Persson	Marketing Manager	5.3yrs	no data	no data

4.9yrs

Average Tenure

45yo

Average Age

Experienced Management: GENI's management team is considered experienced (4.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kenth-Ake Jonsson	Independent Director	15yrs	kr75.00k	no data
Bengt-Arne Molin	Independent Director	4yrs	kr75.00k	0.055% SEK 321.0k
Hans Krantz	Chairman of the Board	14.5yrs	kr150.00k	21.82% SEK 127.9m
Stefan Widen	Independent Director	10yrs	kr75.00k	no data
Johanna Berlinde	Independent Director	less than a year	no data	no data
Erik Ivarsson	Director	2yrs	no data	0.11% SEK 667.8k

7.0yrs

Average Tenure

64.5yo

Average Age

Experienced Board: GENI's board of directors are considered experienced (7 years average tenure).

Generic Sweden Management

Management criteria checks 4/4

Key information

Recent management updates

Less than half of directors are independent

Owner & Member of the board recently sold kr3.5m worth of stock

Owner & Member of the board recently sold kr3.1m worth of stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Recent updates

First quarter 2024 earnings: Revenues exceed analyst expectations

Now 23% undervalued

Upcoming dividend of kr1.50 per share

Now 23% undervalued after recent price drop

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Investor sentiment improves as stock rises 16%

Now 22% undervalued

Third quarter 2023 earnings: Revenues exceed analyst expectations

Investor sentiment improves as stock rises 21%

Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

New major risk - Earnings quality

Investor sentiment improves as stock rises 17%

Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Upcoming dividend of kr1.25 per share at 2.9% yield

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 21%

Full year 2022 earnings: EPS exceeds analyst expectations

Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

Now 21% undervalued

Now 21% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of kr1.00 per share

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Less than half of directors are independent

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Investor sentiment improved over the past week

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.1m worth of stock

Third quarter 2021 earnings released

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Upcoming dividend of kr0.80 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?